ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,353, issued on June 23, was assigned to Yeda Research and Development Co. Ltd. (Rehovot, Israel).
"SPT5 inhibitors and uses thereof" was invented by Rivka Dikstein (Rehovot, Israel) and Anat Bahat (Rehovot, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds which are Spt5 inhibitors and which are for use in the treatment diseases and disorders in which inhibiting one or more activities of Spt5 is beneficial, such as, for example, Trinucleotide repeat disorders, obesity, inflammatory diseases, infectious diseases and cancer. The compounds are represented by Formulae I-VII, as defined in the specification."
The patent was fi...